Wall Street's Most Accurate Analysts Say Hold These 3 Real Estate Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.

Hudson Pacific Properties, Inc. HPP

• Dividend Yield: 21.14%
• Morgan Stanley analyst Ronald Josey maintained an Equal-Weight rating and cut the price target from $6 to $4 on May 30, 2023. This analyst has an accuracy rate of 70%.
• BMO Capital analyst John Kim maintained a Market Perform rating and lowered the price target from $8 to $7 on April 11, 2023. This analyst has an accuracy rate of 67%.
• Recent News: Hudson Pacific Properties reported better-than-expected first-quarter sales results.

SL Green Realty Corp. SLG

• Dividend Yield: 14.17%
• Morgan Stanley analyst Ronald Josey maintained an Equal-Weight rating and cut the price target from $35 to $21 on March 31, 2023. This analyst has an accuracy rate of 70%.
• Evercore ISI Group analyst Steve Sakwa maintained an In-Line rating and slashed the price target from $38 to $33 on March 27, 2023. This analyst has an accuracy rate of 64%.
• Recent News: SL Green Realty posted an increase in sales results for the first quarter.

Sabra Health Care REIT, Inc. SBRA

• Dividend Yield: 11.24%
• Credit Suisse analyst Omotayo Okusanya reiterated a Neutral rating with a price target of $13 on April 12, 2023. This analyst has an accuracy rate of 61%.
• Citigroup analyst Nicholas Joseph maintained a Neutral rating and lowered the price target from $13 to $10.5 on March 28, 2023. This analyst has an accuracy rate of 63%.
• Recent News: Sabra Health Care REIT reported better-than-expected sales results for its first quarter.

Read More: Marvell, Seagate And 2 Other Stocks Insiders Are Selling